Skip to main content
SpringerLink
Log in

COPD

Bald neue LAMA-LABA-Fixkombi?

  • infopharm
  • Published:
Pneumo News Aims and scope

Die Zulassung für eine neue Fixkombination aus dem lang wirksamen Anticholinergikum (LAMA) Tiotropium (T) und dem lang wirksamen Betaagonisten (LABA) Olodaterol (O) in der EU und USA ist beantragt. Fortschritte bei der COPD-Therapie werden erwartet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Quelle

  • Pressekonferenz ERS-Kongress München, 8.9.2014, Veranstalter: Boehringer Ingelheim

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Dagmar Jäger-Becker

Authors
  1. Dagmar Jäger-Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jäger-Becker, D. Bald neue LAMA-LABA-Fixkombi?. Pneumo News 7, 60 (2015). https://doi.org/10.1007/s15033-015-0084-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0084-0

Search

Navigation